1,460
Views
18
CrossRef citations to date
0
Altmetric
Original Articles

Development of an influenza virus protein microarray to measure the humoral response to influenza virus infection in mallards

, , &
Pages 1-9 | Received 18 Aug 2017, Accepted 22 Oct 2017, Published online: 15 Jan 2019

References

  • Webster RG, Bean WJ, Gorman OTet al.Evolution and ecology of influenza A viruses. Microbiol Rev 1992;56: 152–179.
  • Runstadler J, Hill N, Hussein ITet al.Connecting the study of wild influenza with the potential for pandemic disease. Infect Genet Evol 2013;17: 162–187.
  • Ramey AM, Poulson RL, González-Reiche ASet al.Evidence for seasonal patterns in the relative abundance of avian influenza virus subtypes in blue-winged teal (Anas discors). J Wildl Dis 2014;50: 916–922.
  • Latorre-Margalef N, Tolf C, Grosbois Vet al.Long-term variation in influenza A virus prevalence and subtype diversity in migratory mallards in northern Europe. Proc Biol Sci 2014;281: 20140098.
  • Latorre-Margalef N, Brown JD, Fojtik Aet al.Competition between influenza A virus subtypes through heterosubtypic immunity modulates re-infection and antibody dynamics in the mallard duck. PLoS Pathog 2017;13: e1006419.
  • Segovia KM, Stallknecht DE, Kapczynski DRet al.Adaptive heterosubtypic immunity to low pathogenic avian influenza viruses in experimentally infected mallards. PLoS One 2017;12: e0170335.
  • Lee DH, Torchetti MK, Winker Ket al.Intercontinental spread of asian-origin H5N8 to North America through Beringia by migratory birds. J Virol 2015;89: 6521–6524.
  • Ekiert DC, Wilson IA.Broadly neutralizing antibodies against influenza virus and prospects for universal therapies. Curr Opin Virol 2012;2: 134–141.
  • Krammer F.Emerging influenza viruses and the prospect of a universal influenza virus vaccine. Biotechnol J 2015;10: 690–701.
  • Bucukovski J, Latorre-Margalef N, Stallknecht DEet al.A multiplex label-free approach to avian influenza surveillance and serology. PLoS One 2015;10: e0134484.
  • Desbien AL, Van Hoeven N, Reed SJet al.Development of a high density hemagglutinin protein microarray to determine the breadth of influenza antibody responses. Biotechniques 2013;54: 345–348.
  • Vigil A, Davies DH, Felgner PL.Defining the humoral immune response to infectious agents using high-density protein microarrays. Future Microbiol 2010;5: 241–251.
  • Freidl GS, Binger T, Müller MAet al.Serological evidence of influenza A viruses in frugivorous bats from Africa. PLoS One 2015;10: e0127035.
  • Te Beest DE, de Bruin E, Imholz Set al.Heterosubtypic cross-reactivity of HA1 antibodies to influenza A, with emphasis on nonhuman subtypes (H5N1, H7N7, H9N2). PLoS One 2017;12: e0181093.
  • Wumkes ML, van der Velden AM, de Bruin Eet al.Microarray profile of the humoral immune response to influenza vaccination in breast cancer patients treated with chemotherapy. Vaccine 2017;35: 1299–1305.
  • Freidl GS, van den Ham HJ, Boni MFet al.Changes in heterosubtypic antibody responses during the first year of the 2009 A(H1N1) influenza pandemic. Sci Rep 2016;6: 20385.
  • te Beest D, de Bruin E, Imholz Set al.Discrimination of influenza infection (A/2009 H1N1) from prior exposure by antibody protein microarray analysis. PLoS One 2014;9: e113021.
  • Freidl GS, de Bruin E, van Beek Jet al.Getting more out of less—a quantitative serological screening tool for simultaneous detection of multiple influenza A hemagglutinin-types in chickens. PLoS ONE 2014;9: e108043.
  • Boni MF, Chau NV, Dong Net al.Population-level antibody estimates to novel influenza A/H7N9. J Infect Dis 2013;208: 554–558.
  • Mace CR, Topham DJ, Mosmann TRet al.Label-free, arrayed sensing of immune response to influenza antigens. Talanta 2011;83: 1000–1005.
  • Mullarkey CE, Bailey MJ, Golubeva DAet al.Broadly neutralizing hemagglutinin stalk-specific antibodies induce potent phagocytosis of immune complexes by neutrophils in an Fc-dependent manner. MBio 2016;7: e01624–16.
  • Henry Dunand CJ, Leon PE, Huang Met al.Both neutralizing and non-neutralizing human H7N9 influenza vaccine-induced monoclonal antibodies confer protection. Cell Host Microbe 2016;19: 800–813.
  • Dilillo DJ, Tan GS, Palese Pet al.Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo. Nat Med 2014;20: 143–151.
  • Tan GS, Leon PE, Albrecht RAet al.Broadly-reactive neutralizing and non-neutralizing antibodies directed against the H7 influenza virus hemagglutinin reveal divergent mechanisms of protection. PLoS Pathog 2016;12: e1005578.
  • Jegaskanda S, Weinfurter JT, Friedrich TCet al.Antibody-dependent cellular cytotoxicity is associated with control of pandemic H1N1 influenza virus infection of macaques. J Virol 2013;87: 5512–5522.
  • Krammer F, Margine I, Tan GSet al.A carboxy-terminal trimerization domain stabilizes conformational epitopes on the stalk domain of soluble recombinant hemagglutinin substrates. PLoS One 2012;7: e43603.
  • Margine I, Palese P, Krammer F.Expression of functional recombinant hemagglutinin and neuraminidase proteins from the novel H7N9 influenza virus using the baculovirus expression system. J Vis Exp 2013;81: 51112.
  • Heaton NS, Leyva-Grado VH, Tan GSet al.In vivo bioluminescent imaging of influenza a virus infection and characterization of novel cross-protective monoclonal antibodies. J Virol 2013;87: 8272–8281.
  • Hai R, Krammer F, Tan GSet al.Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypes. J Virol 2012;86: 5774–5781.
  • Nachbagauer R, Wohlbold TJ, Hirsh Aet al.Induction of broadly reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humans. J Virol 2014;88: 13260–13268.
  • Margine I, Hai R, Albrecht RAet al.H3N2 influenza virus infection induces broadly reactive hemagglutinin stalk antibodies in humans and mice. J Virol 2013;87: 4728–4737.
  • Liu L, Nachbagauer R, Zhu Let al.Induction of broadly cross-reactive stalk-specific antibody responses to influenza group 1 and group 2 Hemagglutinins by natural H7N9 virus infection in humans. J Infect Dis 2017;215: 518–528.
  • Ellebedy AH, Krammer F, Li GMet al.Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans. Proc Natl Acad Sci USA 2014;111: 13133–13138.
  • Viruses GCfHNaRI.Role for migratory wild birds in the global spread of avian influenza H5N8. Science 2016;354: 213–217.
  • Greene JL Update on the highly-pathogenic avian influenza outbreak of 2014–2015. Available at: https://fas.org/sgp/crs/misc/R44114.pdf2015.
  • Li GM, Chiu C, Wrammert Jet al.Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells. Proc Natl Acad Sci USA 2012;109: 9047–9052.
  • Wrammert J, Koutsonanos D, Li GMet al.Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J Exp Med 2011;208: 181–193.
  • Ryder AB, Nachbagauer R, Buonocore Let al.Vaccination with vesicular stomatitis virus-vectored chimeric hemagglutinins protects mice against divergent influenza virus challenge strains. J Virol 2015;90: 2544–2550.
  • Nachbagauer R, Choi A, Hirsh Aet al.Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins. Nat Immunol 2017;18: 464–473.
  • Wilcox BR, Knutsen GA, Berdeen Jet al.Influenza-A viruses in ducks in northwestern Minnesota: fine scale spatial and temporal variation in prevalence and subtype diversity. PLoS One 2011;6: e24010.